Vivian de Jong

PHD Candidate - OIO

Contact

Recent publications

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity Alina N Saidi, Laura A M Konings, Carmen A W Dietvorst, Vivian D de Jong, Willem Pieter Brouwer, Aart-Jan van der Lelij, Marco Alings, Martien van Wenum, Simone P Rauh, Weiwei Xu, Manuel Castro Cabezas
Diabetes, Obesity & Metabolism, 2025, vol. 27, p.6624-6631

Reply to Vivian D. de Jong, Stella Trompet, J. Wouter Jukema, Diederick E. Grobbee, Manuel Castro Cabezas
JHEP Reports, 2025, vol. 7

Can targeting de novo lipogenesis improve liver health? Manuel Castro Cabezas, Vivian D de Jong
The Lancet. Gastroenterology & hepatology, 2025, vol. 10, p.873-874

Global research initiative for patient screening on MASH (GRIPonMASH) protocol Vivian D de Jong, Marco Alings, Radan Bruha, Helena Cortez-Pinto, George V Dedoussis, Michail Doukas, Sven Francque, Céline Fournier-Poizat, Amalia Gastaldelli, Thomas Hankemeier, Adriaan G Holleboom, Luca Miele, Christophe Moreno, Jean W M Muris, Vlad Ratziu, Manuel Romero-Gomez, Jörn M Schattenberg, Lawrence Serfaty, D Cristina Stefan, Maarten E Tushuizen, Joanne Verheij, José Willemse, Oscar H Franco, Diederick E Grobbee, Manuel Castro Cabezas,
BMJ Open, 2025, vol. 15

Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trial Vivian de Jong, Willy Theel, Manuel Castro Cabezas, Diederick Grobbee, Wouter Jukema, Stella Trompet
JHEP Reports, 2025, vol. 7

Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment Willy B Theel, Vivian D de Jong, Manuel Castro Cabezas, Diederick E Grobbee, Johan W Jukema, Stella Trompet
European Journal of Clinical Investigation, 2024, vol. 55